Gilde Healthcare’s Surgical Instrument Contract Manufacturing Group (“the Group”) has acquired Rudischhauser Surgical Instruments Manufacturing GmbH (“Rudischhauser”), marking a significant milestone in the creation of a leading contract manufacturing group for precision surgical instruments.
Rudischhauser joins the Group alongside Chr. Diener and Koscher & Würtz, bringing the combined organization to approximately 350 highly skilled employees. The acquisition further broadens the Group’s portfolio of precision surgical instruments and strengthens opportunities for knowledge sharing, operational excellence, and best‑practice exchange across its companies.
Headquartered in Tuttlingen, Germany, Rudischhauser develops and manufactures complex surgical instruments and implants for leading international MedTech companies. Founded in 1954, the company brings more than 70 years of technical expertise and a strong reputation for excellent quality and reliability. Today, Rudischhauser is recognized as a specialist in complex, reusable surgical instruments, particularly for spine and orthopedic surgery. The company has built long‑standing customer relationships based on quality, precision, and trust.
Gilde Healthcare established the Group through the acquisitions of Chr. Diener (2022) and Koscher & Würtz (2023), combining reputable surgical instrument manufacturers with decades of market experience. As consolidation in the surgical instrument manufacturing sector accelerates, Gilde Healthcare intends to continue expanding the Group through both strategic acquisitions and organic growth.
Steffen Rudischhauser, owner and Managing Director of Rudischhauser, commented: “We are thrilled to join the Group and view this partnership as an exciting next chapter for our company. It ensures the continuity of our high quality and craftsmanship while providing the scale and resources needed for future growth. The potential for our company to benefit from synergies within the group, particularly in IT and quality management, was another key consideration in taking this step.”
While Steffen Rudischhauser will remain with the company as Managing Director, the second shareholder, Sandra Rudischhauser, will leave the company after a transition period.
Dr. Christian Stark, CEO of the Group, said: “Welcoming Rudischhauser to the Group represents a major milestone in our growth journey. This combination strengthens our position as a comprehensive partner for our clients and enhances our ability to deliver solutions across multiple surgical specialties and therapy fields. We look forward to continuing the Group’s growth organically and through further acquisitions of specialized medical device manufacturers.”
Rafael Natanek, General Partner at Gilde Healthcare Private Equity, commented: “The acquisition of Rudischhauser marks another important step in building our vision of a leading surgical instrument contract manufacturing group. Rudischhauser’s exceptional manufacturing capabilities, strong customer relationships, and complementary product portfolio make it an ideal addition to the Group.”
About Rudischhauser
Rudischhauser is specialized in the manufacturing of complex surgical instruments and implants. They serve leading international MedTech companies especially in the spine, orthopedics, and traumatology space. Founded in 1954, the company provides advanced manufacturing processes and state-of-the-art quality certifications including FDA compliance. www.rudischhauser.com
About Koscher & Würtz and Chr. Diener
Gilde Healthcare acquired Chr. Diener in 2022 and Koscher & Würtz in 2023 to form a specialized group of contract manufacturers for complex surgical instruments. The two companies combine over 160 years of experience manufacturing a wide range of both reusable and disposable surgical instruments for leading international MedTech companies. www.koscher-wuertz.de www.diener-gmbh.de
About Gilde Healthcare
Gilde Healthcare is a thematic investor managing over €2.6 billion across two healthcare-focused fund strategies: Private Equity and Venture & Growth. Gilde Healthcare’s private equity fund invests in profitable lower mid-market healthcare companies based in Northwest Europe. Gilde Healthcare’s Venture & Growth fund invests in digital healthcare solutions, medical technology, and therapeutics based in Europe and North America. www.gildehealthcare.com
